2026 ASH®
Annual Meeting & Exposition December 12-15, 2026 ▪ New Orleans, Louisiana

Paper Details

Abstracts, authors, affiliations, and disclosures.

SESSION

602. Myeloid Oncogenesis: Basic: Poster III

Program: Poster Abstract Session
Monday, December 14, 2026
06:00 p.m. - 08:00 p.m.
MCCNO - Hall F
Technology and Procedures, Assays, Imaging, Omics Technologies, Bioinformatics, Gene Editing, Profiling, Treatment Considerations, Combination Therapy, Drug Development, Non-Biological Therapies, Chemotherapy, Biological Processes, Apoptosis, Pathogenesis, Genomics, Hematopoiesis, Immune Mechanism, Metabolism, Molecular Biology, Diseases, Myeloid Malignancies, Acute Myeloid Malignancies, Chronic Myeloid Malignancies, Metabolic Disorders, Research, Fundamental Science, AML, Translational Research, CML, Study Population, Human, Animal Model
PAPER

4968 A SIRT5-associated mitochondrial ribosomal protein network regulates electron transport chain function in acute myeloid leukemia

Yulieth X Torres, MS, PhD, Alexandria Van Scoyk, BS2, Nataly Cruz-Rodriguez, PhD3, Michael Deininger, MD, PhD4
1 University of Michigan, Ann Arbor, Michigan, United States
2 University of Utah, Salt Lake City, Utah, United States
3 University of Michigan, Ann Arbor, Michigan, United States
4 University of Michigan, Ann Arbor, Michigan, United States

Background

Lysine acylation is a posttranslational modification that regulates fundamental cellular processes, including metabolism, by controlling protein localization, stability, or catalytic activity. While acetylation is mediated by acetyl transferases, acylation (e.g., the transfer of succinyl from succinyl-CoA) occurs through nucleophilic attack by the ε amino group in a non-enzymatic fashion. SIRT5 is a lysine deacylase that removes dicarboxylic acyl groups (e.g., succinyl, malonyl, glutaryl) from solvent-exposed lysines, thereby controlling acylation stoichiometry. This is particularly important in the mitochondrial matrix, where high pH promotes nucleophilic attack by deprotonation of the ε amino group.

SIRT5 is implicated in the regulation of key metabolic pathways, including oxidative phosphorylation (OXPHOS). Prior work from our group (Yan D et al. 2021. PMID: 34027418) and others (Zhang et al. 2024. PMID: 38585637; Wang, M et al. Leukemia. 2025. PMID: 40588567) has shown that a subset of acute myeloid leukemia (AML) cases requires SIRT5 to maintain OXPHOS, implicating SIRT5 as a therapy target. As SIRT5 dependence is neither correlated with SIRT5 expression levels, nor associated with specific genotypes, we hypothesized that distinct SIRT5 protein interaction networks may govern dependence.

Methods

To map the SIRT5 interactome in AML, we engineered SIRT5‑dependent (OCI‑AML2, SKM‑1) and SIRT5‑independent (KG‑1a, OCI‑AML3) AML cell lines to stably express SIRT5–TurboID. TurboID is an engineered biotin ligase that becomes highly active upon biotin addition, enabling efficient labeling within a ~10 nm radius to identify transient, weak, or spatially restricted interactions in living cells (Branon TC et al., Nat Biotechnol. 2018. PMID: 30125270). Cells were cultured under biotin‑depleted conditions and then exposed to biotin to induce proximity labeling. Biotinylated proteins were enriched using streptavidin beads and analyzed by mass spectrometry. Differentially enriched proteins were identified using fold‑change thresholds (Log2FC > 2.0) and functional annotation tools. Candidate interactions were validated by confocal microscopy and co‑immunoprecipitation (Co‑IP). Cell lines were subjected to RNA sequencing and immunoblotting.

Results

We identified 103 and 221 enriched proteins in OCI‑AML2 and SKM‑1 cells (SIRT5-dependent) and 103 and 169 proteins in OCI‑AML3 and KG‑1a (SIRT5-independent), respectively. Functional enrichment showed that proteins in SIRT5‑independent cells mapped to diverse processes, whereas proteins enriched in SIRT5‑dependent cells were almost exclusively associated with pathways located in the mitochondrial matrix and/or inner mitochondrial membrane. Twelve proteins were reproducibly enriched across both SIRT5‑dependent lines. Protein interaction analysis revealed that these 12 proteins form a highly interconnected network containing five mitochondrial ribosomal proteins (MRPS9, MRPS10, MRPS14, MRPS31, MRPS35), potentially linking SIRT5 to mitochondrial translation and, considering that the mitochondrial genome codes for critical components of the electron transport chain, to OXPHOS. Confocal microscopy revealed increased co‑localization between SIRT5 and MRPS31 in SIRT5‑dependent compared to SIRT5-independent AML cells, and Co‑IP validated the physical interaction between SIRT5 and MRPS9, providing orthogonal evidence that components of the mitochondrial ribosome form a distinct SIRT5‑associated network in SIRT5‑dependent AML cells. We next quantified MRPS transcripts and protein expression in dependent and independent cell lines. While MRPS protein levels were comparable across cell lines, MRPS10 and MRPS31 transcripts were significantly more abundant in SIRT5‑dependent cells, with trends toward higher MRPS9, MRPS14, and MRPS35. This suggests that SIRT5‑dependent cells are under stress to maintain MRPS protein abundance to support OXPHOS, and that SIRT5 may promote MRPS protein function and/or stability through diacylation of key lysines. Experiments are underway to map SIRT5-regulated MRSP lysines and assess their requirement for mitochondrial translation.

Conclusions

SIRT5-dependent AML cells are characterized by a distinct mitochondrial ribosomal SIRT5 interactome that may play a critical role for maintaining mitochondrial translation and electron transport chain function, for the first time mechanistically linking SIRT5 and OXPHOS.

Yulieth X Torres, MS, PhD: No relevant conflicts of interest to declare.